Amgen

Open: 220.1 Close: 217.46 Change: -2.64

Our AI found 7 flaws in Amgen.

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, FTC, acquisition, Horizon, Supreme, Therapeutics, patent, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

FTC said it opposed the deal because of concerns Amgen would leverage its big selling drugs. Elizabeth Warren wrote a blistering letter opposing Amgen acquisition of Horizon.

Today's News

Elizabeth Warren wrote a blistering letter opposing Amgen acquisition of Horizon Therapeutics. The biotech company is facing a patent cliff scarier than Washingtons actions. Amgen Inc. pushes to unseal Regeneron-Viatris Eylea case filings. FDA approves Opiants opioid overdose nasal spray. FTC said it opposed the deal because of concerns Amgen would leverage its big selling drugs. J&J in mid-March renewed its bid to block Amgen from launching ABP 654 while the case continues. Amgen sued rival Novartis AG on May 1 in a New Jersey federal court alleging its proposed biosimilar versions of bone-strengthening drugs Prolia and XVEVA infringe Amgen patents. Federal Trade Commission is expected to introduce a lawsuit to block the proposed $27.8 billion merger with Amgen. Pfizers acquisition of Seagen could also run into problems, too? U.S. district court issues temporary restraining order on $27.8 bln Amgen-Horizon deal. FTC effort to stop Amgens Horizon takeover faces uphill fight. FTC faces uphill battle in its fight against Amgen Inc. The Supreme Court unanimously affirmed that Amgen failed to enable an ordinary artisan to make and use all that was claimed. The two methods for discovering new antibodies were simply invitations for scientists to engage in their own trial-and-error discovery processes. The Value Marketing Senior Manager for Cardiovascular Health System Solutions will serve as a cross-functional lead for developing and executing Amgens targeted health system strategy and marketing capabilities within the U.S. At Amgen, our shared mission-to serve patients-drives. FTC announced that it planned to stop Amgens $27.8 billion acquisition of Horizon Therapeutics last week. FTC cited threat of monopolization in treatments for thyroid eye disease and chronic refractory gout. Amgen v. Sanofi: The Supreme Court Takes up the Enablement Requirement in the Context of Therapeutic Monoclonal Antibodies. U.S. Supreme Court rules against Amgen in patent infringement case between Sanofi and Regeneron. Federal Trade Commission filed lawsuit to block Amgens $27.8 billion proposed acquisition of Horizon Therapeutics. Wall Street is sidelined on Amgen, with a Hold consensus rating. The main responsibility of the role is to support applications, design and solution deployment working with partners in Quality, Manufacturing, and Engineering. Amgen offers a Total Rewards Plan with health and welfare plans for staff and eligible dependents. The Supreme Court upheld this decision in Amgen v. Sanofi welcomed the Supreme Courts verdict, stating that this development marks an “unequivocal win for Americas innovation economy” Federal Trade Commission sued to block Amgen Inc. purchase of Horizon Therapeutics plc. FTC alleges that the acquisition would allow Amgen to leverage its portfolio of blockbuster drugs in negotiations with insurance companies and pharmacy benefit managers. U.S. Supreme Court rules against Amgens bid to revive cholesterol-lowering drug Repatha patents. Amgen settles J&J patent lawsuit over drug similar to blockbuster Stelara. FTC is attempting to stop the sale out of fears it will give Amgen too much power. Federal Trade Commission sues to block Amgen acquisition of Horizon Therapeutics. FTC is preparing to seek an injunction in federal court that would prevent the deal.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, FTC, acquisition, Horizon, Supreme, Therapeutics, patent, and the most common words in the summary are: amgen, stock, job, market, patent, amgens, price, . One of the sentences in the summary was: Elizabeth Warren wrote a blistering letter opposing Amgen acquisition of Horizon.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #job #market #patent #amgens #price.